Genetics

This blog post examines research showing that the relationship between serum lipids and disability progression in multiple sclerosis may depend partly on an individual’s genetic background. In a five-year longitudinal cohort, the authors identified several lipid-related genetic variants that, when combined into a cumulative risk score, were associated with faster increases in Expanded Disability Status Scale scores. The strongest effects emerged through interactions with HDL cholesterol and the total cholesterol-to-HDL ratio, suggesting that adverse lipid profiles may be particularly consequential in genetically susceptible individuals. Although the findings require replication in larger independent cohorts, they provide a compelling framework for integrating metabolic biomarkers, genetic risk assessment and future precision-treatment strategies in multiple sclerosis.